Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma.
Oncologist
; 27(6): e463-e470, 2022 06 08.
Article
in En
| MEDLINE
| ID: mdl-35348754
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pyridines
/
Melanoma
/
Neoplasm Recurrence, Local
Limits:
Humans
Language:
En
Year:
2022
Type:
Article